Salvador L M, Mukherjee S, Kahn R A, Lamm M L, Fazleabas A T, Maizels E T, Bader M F, Hamm H, Rasenick M M, Casanova J E, Hunzicker-Dunn M
Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
J Biol Chem. 2001 Sep 7;276(36):33773-81. doi: 10.1074/jbc.M101498200. Epub 2001 Jul 11.
Previously we demonstrated in a cell-free ovarian follicular plasma membrane model that agonist-dependent desensitization of the luteinizing hormone/choriogonadotropin receptor (LH/CG R) is GTP-dependent, mimicked by the addition of ADP-ribosylation factor (ARF) nucleotide binding site opener, which acts as a guanine nucleotide exchange factor for ARFs 1 and 6, and selectively inhibited by synthetic N-terminal ARF6 peptides. We therefore sought direct evidence that activation of the LH/CG R promotes activation of ARF1 and/or ARF6. Using a classic ARF activation assay, the cholera toxin-catalyzed ADP-ribosylation of G alpha(s), results show that LH/CG R activation stimulates an ARF protein by a brefeldin A-independent mechanism. Synthetic N-terminal inhibitory ARF6 but not ARF1 peptide blocks LH/CG R-stimulated ARF activity. LH/CG R activation also promotes the binding of a photoaffinity GTP analog to a protein that migrates on one- and two-dimensional polyacrylamide gel electrophoresis with ARF6. These results suggest that ARF6 is the predominant ARF activated by the LH/CG R. To activate ARF6, the LH/CG R does not appear to signal through the C-terminal regions of G alpha(i) or G alpha(q) or through the second or third intracellular loops or the N terminus of the cytoplasmic tail of the LH/CG R. Although exogenous recombinant ARNO promotes only a small increase in ARF6 activation in the presence of activated LH/CG R, hCG-stimulated ARF6 activation is reduced to basal levels by catalytically inactive ARF nucleotide binding-site opener. These results provide direct evidence that LH/CG R activation leads to the activation of membrane-delimited ARF6.
此前我们在无细胞的卵巢卵泡质膜模型中证明,促黄体生成素/绒毛膜促性腺激素受体(LH/CG R)的激动剂依赖性脱敏是GTP依赖性的,可通过添加ADP-核糖基化因子(ARF)核苷酸结合位点开放剂来模拟,该开放剂可作为ARF 1和6的鸟嘌呤核苷酸交换因子,并被合成的N端ARF6肽选择性抑制。因此,我们寻求直接证据,以证明LH/CG R的激活会促进ARF1和/或ARF6的激活。使用经典的ARF激活试验,即霍乱毒素催化的Gα(s)的ADP核糖基化,结果表明,LH/CG R激活通过一种不依赖布雷菲德菌素A的机制刺激ARF蛋白。合成的N端抑制性ARF6肽而非ARF1肽可阻断LH/CG R刺激的ARF活性。LH/CG R激活还促进了光亲和性GTP类似物与一种在一维和二维聚丙烯酰胺凝胶电泳上与ARF6一起迁移的蛋白质的结合。这些结果表明,ARF6是被LH/CG R激活的主要ARF。为了激活ARF6,LH/CG R似乎并非通过Gα(i)或Gα(q)的C端区域,或通过LH/CG R细胞质尾巴的第二个或第三个细胞内环或N端来传递信号。尽管在激活的LH/CG R存在的情况下,外源性重组ARNO仅使ARF6激活略有增加,但hCG刺激的ARF6激活会被催化失活的ARF核苷酸结合位点开放剂降低至基础水平。这些结果提供了直接证据,证明LH/CG R激活会导致膜结合的ARF6激活。